Respiratory Hypersensitivity: Clinical Trials

5,612 trials for Respiratory Hypersensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3925 completed, 600 unknown, 348 recruiting, 271 terminated. 1408 Not applicable, 895 Phase 3, 893 Phase 2, 594 Phase 4, 501 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1408Completed 902, Unknown 205, Recruiting 108, Not yet recruiting 64, Terminated 50, Withdrawn 41, Active not recruiting 26, Enrolling by invitation 8, Suspended 4
Phase 3895Completed 708, Unknown 49, Recruiting 41, Terminated 39, Withdrawn 32, Active not recruiting 13, Not yet recruiting 11, Enrolling by invitation 1, Suspended 1
Phase 2893Completed 666, Terminated 65, Withdrawn 45, Unknown 43, Recruiting 41, Active not recruiting 20, Not yet recruiting 11, Enrolling by invitation 2
Phase 4594Completed 437, Unknown 58, Terminated 42, Recruiting 16, Withdrawn 16, Active not recruiting 13, Not yet recruiting 10, Enrolling by invitation 2
Phase 1501Completed 395, Terminated 38, Unknown 23, Withdrawn 17, Recruiting 14, Active not recruiting 8, Not yet recruiting 6
Early Phase 133Completed 20, Terminated 4, Unknown 4, Active not recruiting 3, Enrolling by invitation 1, Recruiting 1

Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EFFECT OF AYURVEDA TREATMENT IN ALLERGIC RHINITIS
AYURVEDA treatment protocol, Control(Citrizine 10mg) - Allergic Rhinitis (AR)
Not applicableNot yet recruitingAmrita Vishwa Vidyapeetham1042028-06-302026-06-04
Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)
linvemastat, Placebo - Asthma (Diagnosis), Pulmonary Function
Phase 2Not yet recruitingForesee Pharmaceuticals Co., Ltd.1352027-03-012026-07-20
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
HDM sublingual Immunotherapy, Placebo - Asthma, Allergy
Phase 2WithdrawnBoston Children's Hospital2027-02-012024-11-26
Prevent Wheeze Trial
Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing
Phase 4Not yet recruitingNorwegian University of Science and Technology4862027-02-012026-10-05
Changes in Symptom and Quality of Life in Patients With Uncontrolled Asthma Treated With Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI)
Budesonide/Glycopyrronium/Formoterol fumarate metered dose inhaler - Asthma, Uncontrolled Asthma
Not yet recruitingAstraZeneca2002027-01-292026-11-12
Educational Needs of Patients With Severe Asthma on Targeted Immunotherapies
Initial assesment interwiew, Intake Interview with the Patient - Severe Asthma
Not yet recruitingUniversity Hospital, Angers202027-01-042026-10-02
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
Slow Release DHEA, Placebo - Asthma
Phase 2Not yet recruitingIndiana University302027-01-012026-02-27
Nebulized Ketamine for Severe Asthma Attacks in Children
Ketamine (1 mg/kg), Placebo - Asthma Acute, Exacerbation of Allergic Asthma
Phase 2Not yet recruitingSultan Qaboos University602027-01-012026-07-27
Pulmonary Rehabilitation in African Countries
Centre-based Pulmonary Rehabilitation, Community-based Pulmonary Rehabilitation - Chronic Respiratory Conditions
Not applicableNot yet recruitingUniversity of Edinburgh1502027-01-012026-11-09
Sustainable Inhaler Prescribing in Intermediate Care Units
Multidisciplinary inhaler optimization intervention - Pulmonary Disease, Chronic Obstructive (COPD), Asthma (Diagnosis)
Not applicableNot yet recruitingConsorci Sanitari de l'Alt Penedès i Garraf1102027-01-012026-11-12
Sustained Asthma Remission and Reduced Relapse Using a Comprehensive Management Strategy (SARRE-COMS)
Comprehensive Biomarker-Guided Management Strategy, Standard of Care - Asthma (Diagnosis)
Not applicableNot yet recruitingHana Serajeddini502026-12-022026-09-25
Development and Validation of the Indian Asthma Care Bundle for Reducing Readmission and Improving Post-hospitalisation Care After Discharge From Hospital Due to an Acute Asthma Exacerbation
Indian Asthma Care Bundle (I-ACB) - Asthma Exacerbation, Asthma (Diagnosis)
Not applicableNot yet recruitingAhmedabad University2602026-12-012026-09-11
Study of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate Asthma
HXN-1013, Placebo - Health Adults, Asthma
Phase 1Not yet recruitingHelixon Biotechnology (Suzhou) Co., Ltd402026-12-012026-10-28
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
Severe Asthma, Chronic Rhinosinusitis With Nasal Polyps(CRSwNP)
Not yet recruitingAstraZeneca2102026-11-282026-06-04
Asthma Ctrl SMART Trial
Asthma Ctrl, Asthma Ctrl+, Control - Asthma in Children, Asthma Chronic
Not applicableNot yet recruitingChildren's Hospital Medical Center, Cincinnati3892026-11-232026-11-04
Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma
CHF5993 100/6/12.5 μg pMDI HFA-152a, Seretide Evohaler - Asthma
Phase 3Not yet recruitingChiesi Farmaceutici S.p.A.7002026-11-162026-10-05
Changing Lifestyle to Improve Quality of Life in Spanish Adolescents With Asthma
Lifestyle-change intervention - Asthma (Diagnosis)
Not applicableNot yet recruitingUniversitat Internacional de Catalunya962026-11-022026-10-22
R34 Asthma Depression
SAMBA, Cognitive Behavioral Therapy-Asthma Depression (CBT-AD), Original SAMBA - Asthma, Depression
Not applicableNot yet recruitingIcahn School of Medicine at Mount Sinai602026-11-012026-10-26
Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma
Depemokimab - Allergic Bronchopulmonary Aspergillosis, ABPA
Not applicableNot yet recruitingQianfoshan Hospital102026-11-012026-09-24
Post-market Clinical Follow-up Study of an Isotonic Saline Solution for the Relief of Nasal Congestion in Infants and Toddlers
Quinton Medical Nasal Health Baby® - Nasal Congestion, Common Cold
Not yet recruitingLaboratoires Quinton International S.L.832026-11-012026-10-13

Showing 20 of 5612. Sign in to see all of them.

Narrower conditions

Asthma (4474)  ·  Rhinitis, Allergic (682)  ·  Pulmonary Disease, Chronic Obstructive (447)  ·  Rhinitis, Allergic, Seasonal (384)  ·  Hypersensitivity (270)  ·  Rhinitis, Allergic, Perennial (178)  ·  Lung Diseases (150)  ·  Rhinitis (106)  ·  Obesity (94)  ·  Disease (92)  ·  Inflammation (79)  ·  Respiratory Sounds (75)  ·  Dyspnea (68)  ·  Heart Failure (68)  ·  Diabetes Mellitus (67)

Broader conditions

Hypersensitivity, Immediate (5595)  ·  Immune System Diseases (5591)  ·  Respiratory Tract Diseases (5555)  ·  Hypersensitivity (5342)  ·  Bronchial Diseases (4524)  ·  Lung Diseases, Obstructive (4446)  ·  Lung Diseases (4416)  ·  Otorhinolaryngologic Diseases (1209)  ·  Nose Diseases (1188)  ·  Rhinitis (1055)  ·  Pathological Conditions, Signs and Symptoms (1007)  ·  Pathologic Processes (700)  ·  Disease Attributes (515)  ·  Chronic Disease (456)

Interventions

Fluticasone (214)  ·  Budesonide (189)  ·  montelukast (172)  ·  Albuterol (159)  ·  Formoterol Fumarate (105)  ·  Mometasone Furoate (94)  ·  Beclomethasone (87)  ·  Fluticasone-Salmeterol Drug Combination (86)  ·  Salmeterol Xinafoate (80)  ·  Budesonide, Formoterol Fumarate Drug Combination (79)  ·  Omalizumab (78)  ·  fluticasone furoate (57)  ·  ciclesonide (54)  ·  benralizumab (50)  ·  mepolizumab (49)

Sponsors

AstraZeneca (339)  ·  GlaxoSmithKline (324)  ·  Organon and Co (127)  ·  Novartis Pharmaceuticals (81)  ·  National Heart, Lung, and Blood Institute (NHLBI) (76)  ·  Boehringer Ingelheim (66)  ·  Chiesi Farmaceutici S.p.A. (62)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (55)  ·  Sanofi (50)  ·  Imperial College London (48)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (42)  ·  Brigham and Women's Hospital (41)  ·  University of California, San Francisco (35)  ·  National Institute of Environmental Health Sciences (NIEHS) (34)  ·  Johns Hopkins University (33)

Countries

United States (1857)  ·  United Kingdom (566)  ·  Canada (484)  ·  Germany (462)  ·  China (332)  ·  France (324)  ·  Poland (279)  ·  Spain (246)  ·  Italy (197)  ·  Netherlands (172)  ·  Russia (165)  ·  South Korea (162)  ·  Argentina (155)  ·  Belgium (154)  ·  Brazil (149)

Top investigators

Louis-Philippe Boulet, MD (20)  ·  Elliot Israel, MD (15)  ·  Luo Zhang (13)

Results publications

PMID 36472162, PMID 27881132, PMID 39393433, PMID 31319851, PMID 29400693, PMID 32926419, PMID 35691614, PMID 33217063, PMID 38127464, PMID 19001265, PMID 26704701, PMID 30954640, PMID 18331513, PMID 22329608, PMID 24184147, PMID 28065396, PMID 29174062, PMID 29536781, PMID 29656145, PMID 32180164, PMID 33305842, PMID 34098955, PMID 35636689, PMID 10573240, PMID 14713908, PMID 20075384, PMID 20851928, PMID 21060320, PMID 21439168, PMID 22464647, PMID 23374268, PMID 24035151, PMID 24838406, PMID 24966061, PMID 26369589, PMID 26498386, PMID 26612545, PMID 28602936, PMID 29768147, PMID 29768149, PMID 30802500, PMID 30876830, PMID 31047111, PMID 31251094, PMID 31447130, PMID 31613151, PMID 31760132, PMID 31798645, PMID 32298853, PMID 33223095

NIH funding

2015 (31), 2016 (30), 2009 (25), 2014 (24), 2023 (23), 2018 (20), 2017 (19), 2019 (18), 2025 (16), 2008 (13), U10HL098115 (8), 2004 (6), U10HL074212 (6), 2005 (5), P01HL107202 (5)